Adefovir dipivoxil

This classification denotes an acyclic nucleotide adenine antiviral with the molecular formula C20H32N5O8P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U6Q8Z01514, chemically known as propanoic acid, 2,2-dimethyl-, (((2-(6-amino-9h-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) ester but more generally known as adefovir dipivoxil, which bears US NIH Compound Identifier 60871. European Medicines Agency schedules Adefovir dipivoxil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12454MIG. World Health Organization schedules adefovir dipivoxil in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule adefovir dipivoxil under HS 29335995 and SITC 51576. As of Q4 2014, ADEFOVIR DIPIVOXIL remains US FDA's Preferred Term for this commodity. Adefovir dipivoxil bears US NLM identifiers UMLS ID C0540694 and NCI Concept Code C28811. SMILES: CC(C)(C)C(=O)OCOP(=O)(COCCN1CNC2C1NCNC2N)OCOC(=O)C(C)(C)C.